HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Osteonectin influences growth and invasion of pancreatic cancer cells.

AbstractOBJECTIVE:
We sought to examine the expression and functional role of osteonectin in primary and metastatic pancreatic ductal adenocarcinoma (PDAC).
BACKGROUND:
The glycoprotein osteonectin plays a vital role in cell-matrix interactions and is involved in various biologic processes. Overexpression of osteonectin is present in malignant tumors and correlates with disease progression and poor prognosis.
METHODS:
Expression of osteonectin was analyzed by quantitative polymerase chain reaction and immunohistochemistry in pancreatic tissues and by enzyme-linked immunosorbent assay in the serum of patients and donors. Recombinant osteonectin and specific antisense oligonucleotides were used to examine the effects of osteonectin on induction of target genes, and on proliferation and invasiveness of pancreatic cancer cells.
RESULTS:
There was a 31-fold increase in osteonectin mRNA levels in PDAC and a 16-fold increase in chronic pancreatitis as compared with the normal pancreas (P < 0.01). By immunohistochemistry, faint immunoreactivity was detected in the normal pancreas. In contrast, strong staining of the cancer cells was observed in addition to extensive osteonectin immunoreactivity in surrounding fibroblasts and in the extracellular matrix. In metastatic tissues, strong immunoreactivity was observed in fibroblasts and in extracellular matrix surrounding metastatic cancer cells, whereas the signal was absent in most tumor cells. In vitro studies showed that osteonectin was able to inhibit cancer cell growth while promoting invasiveness of pancreatic tumor cells.
CONCLUSION:
Osteonectin is markedly overexpressed in pancreatic cancer and has the potential to increase the invasiveness of pancreatic cancer cells.
AuthorsAhmed Guweidhi, Jörg Kleeff, Hassan Adwan, Nathalia A Giese, Moritz N Wente, Thomas Giese, Markus W Büchler, Martin R Berger, Helmut Friess
JournalAnnals of surgery (Ann Surg) Vol. 242 Issue 2 Pg. 224-34 (Aug 2005) ISSN: 0003-4932 [Print] United States
PMID16041213 (Publication Type: Journal Article)
Chemical References
  • Oligonucleotides, Antisense
  • Osteonectin
  • RNA, Messenger
  • Recombinant Proteins
Topics
  • Adenocarcinoma (genetics, mortality, pathology)
  • Adult
  • Aged
  • Disease Progression
  • Enzyme-Linked Immunosorbent Assay
  • Extracellular Matrix (chemistry)
  • Female
  • Fibroblasts (chemistry)
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Neoplasm Invasiveness (physiopathology)
  • Oligonucleotides, Antisense (pharmacology)
  • Osteonectin (analysis, genetics, physiology)
  • Pancreatic Neoplasms (genetics, mortality, pathology)
  • Pancreatitis (metabolism)
  • Polymerase Chain Reaction
  • Prognosis
  • RNA, Messenger (analysis)
  • Recombinant Proteins (pharmacology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: